Tag:

Epigenomics

Latest Headlines

Latest Headlines

Epigenomics, Qiagen enter colorectal cancer test agreement

Epigenomics and Qiagen have entered an option agreement allowing the latter to develop and potentially commercialize a colorectal cancer blood test based on Epigenomics' proprietary biomarker mSEPT9